POU3F2 and melanoma: This is important, as melanomas and likely other BRN2-expressing cancers exhibit high levels of phenotypic heterogeneity, with BRN2 expression within tumors restricted to a subpopulation of cells associated with invasion (Goodall et al. 2008; Pinner et al. 2009; Zeng et al. 2018).